Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
2007. Free Cash Flow. $1.5 billion. $859 million. $900 million. $380 million. $710 million. Source: S&P Capital IQ. Now we know how much cash AmerisourceBergen is really pulling in each year.
For premium support please call: 800-290-4726 more ways to reach us
It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When judging a company's prospects, how ...
File:AmerisourceBergen logo.svg. Size of this PNG preview of this SVG file: 800 × 218 pixels. Other resolutions: 320 × 87 pixels | 640 × 174 pixels | 1,024 × 279 pixels | 1,280 × 349 pixels | 2,560 × 698 pixels. Original file (SVG file, nominally 1,024 × 279 pixels, file size: 14 KB) This is a file from the Wikimedia Commons.
1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen.
For premium support please call: 800-290-4726 more ways to reach us
Michael Dennis DiCandilo. 1961 (age 62–63) Nationality (legal) American. Occupation. businessman. Michael Dennis DiCandilo (born 1961) is an American businessman who was chief financial officer and executive vice president of AmerisourceBergen Corporation. He served as CFO from 2002 to February 2012. and won the 2011 Institutional Investor ...